Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May;45(5):557-9.
doi: 10.1016/j.ijantimicag.2015.01.006. Epub 2015 Feb 16.

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand

Natnaree Saiprom  1 , Premjit Amornchai  2 , Vanaporn Wuthiekanun  2 , Nicholas P J Day  3 , Direk Limmathurotsakul  4 , Sharon J Peacock  5 , Narisara Chantratita  6
Affiliations

Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand

Natnaree Saiprom et al. Int J Antimicrob Agents. 2015 May.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Trimethoprim/sulfamethoxazole minimum inhibitory concentrations (MICs) for Burkholderia pseudomallei from 3038 patients with primary melioidosis presenting to a hospital in northeast Thailand between 2004 and 2012. MICs were determined using the Etest. The numbers above each column represent the number of isolates with the corresponding MIC. The table shows the total and annual number of B. pseudomallei isolates tested, the MIC50 (concentration that inhibits 50% of bacterial isolates) and the percentage resistant.
See this image and copyright information in PMC

References

    1. Wiersinga W.J., Currie B.J., Peacock S.J. Melioidosis. N Engl J Med. 2012;367:1035–1044. - PubMed
    1. Chetchotisakd P., Chierakul W., Chaowagul W., Anunnatsiri S., Phimda K., Mootsikapun P. Trimethoprim–sulfamethoxazole versus trimethoprim–sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet. 2014;383:807–814. - PMC - PubMed
    1. Wuthiekanun V., Cheng A.C., Chierakul W., Amornchai P., Limmathurotsakul D., Chaowagul W. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother. 2005;55:1029–1031. - PubMed
    1. Dance D.A., Davong V., Soeng S., Phetsouvanh R., Newton P.N., Turner P. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei. Int J Antimicrob Agents. 2014;44:368–369. - PMC - PubMed
    1. Clinical and Laboratory Standards Institute . CLSI; Wayne, PA: 2010. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline—second edition. Document M45-A2.

Publication types

MeSH terms

Substances